Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35,838	22,555	32,012	35,749	76,786	35,439
Market Cap Growth	27.17%	-29.54%	-10.45%	-53.44%	116.67%	-
Enterprise Value	30,728	22,818	31,823	33,878	71,142	29,114
Last Close Price	49.73	38.48	54.26	60.32	128.99	59.08
PE Ratio	54.19	46.13	87.34	64.61	129.11	77.43
Forward PE	54.65	89.61	89.61	89.61	89.61	56.23
PS Ratio	10.90	7.63	15.14	14.65	32.49	23.67
PB Ratio	1.69	1.49	2.17	2.38	5.23	3.09
P/TBV Ratio	2.12	2.08	3.06	3.52	7.77	3.49
P/OCF Ratio	85.74	27.48	56.22	44.48	132.69	68.82
EV/Sales Ratio	9.35	7.71	15.05	13.88	30.10	19.45
EV/EBITDA Ratio	35.99	33.56	70.52	50.43	106.53	51.48
EV/EBIT Ratio	59.63	62.70	192.23	83.32	142.50	65.10
Debt / Equity Ratio	0.01	0.13	0.12	0.08	0.05	-
Debt / EBITDA Ratio	0.32	2.79	3.94	1.68	1.11	-
Asset Turnover	0.16	0.16	0.12	0.14	0.17	0.17
Inventory Turnover	1.78	1.60	1.01	1.17	1.56	1.01
Quick Ratio	5.86	1.99	1.70	4.75	8.14	16.89
Current Ratio	6.94	2.53	2.22	5.95	9.36	19.42
Return on Equity (ROE)	3.09%	3.18%	2.74%	4.12%	4.84%	5.67%
Return on Assets (ROA)	1.57%	1.20%	0.56%	1.49%	2.20%	3.08%
Return on Capital (ROIC)	1.73%	1.36%	0.63%	1.61%	2.32%	3.40%
Return on Capital Employed (ROCE)	2.40%	2.30%	1.10%	2.50%	3.30%	3.80%
Earnings Yield	1.66%	2.17%	1.15%	1.55%	0.78%	1.29%
FCF Yield	-0.91%	-0.10%	-3.13%	-9.50%	-1.15%	-0.70%
Dividend Yield	0.80%	1.04%	0.35%	0.30%	0.25%	0.97%
Payout Ratio	53.00%	28.80%	37.58%	37.39%	57.11%	0.85%
Buyback Yield / Dilution	-10.81%	-0.05%	0.10%	0.11%	-7.38%	-6.91%
Total Shareholder Return	-10.00%	0.99%	0.45%	0.41%	-7.13%	-5.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.